Title | Type | ![]() |
H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | %Female (2022) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Journal for ImmunoTherapy of Cancer![]() | journal | 3.403 Q1 | 117 | 531 | 1395 | 22237 | 14506 | 1384 | 9.00 | 41.88 | 42.18 | ![]() |
2 | Protein and Cell![]() | journal | 3.367 Q1 | 94 | 78 | 281 | 4426 | 2375 | 151 | 10.60 | 56.74 | 37.50 | ![]() |
3 | npj Vaccines![]() | journal | 3.197 Q1 | 47 | 166 | 304 | 8553 | 2772 | 293 | 9.34 | 51.52 | 45.16 | ![]() |
4 | Emerging Microbes and Infections![]() | journal | 2.815 Q1 | 94 | 280 | 697 | 10982 | 7654 | 580 | 12.49 | 39.22 | 46.61 | ![]() |
5 | Theranostics![]() | journal | 2.381 Q1 | 158 | 480 | 1928 | 36470 | 23880 | 1928 | 12.09 | 75.98 | 40.75 | ![]() |
6 | Molecular Therapy - Nucleic Acids![]() | journal | 1.947 Q1 | 95 | 292 | 963 | 16402 | 8540 | 959 | 8.54 | 56.17 | 41.35 | ![]() |
7 | Particle and Fibre Toxicology![]() | journal | 1.805 Q1 | 119 | 68 | 155 | 5344 | 1549 | 154 | 10.11 | 78.59 | 43.38 | ![]() |
8 | Therapeutic Advances in Neurological Disorders![]() | journal | 1.728 Q1 | 68 | 80 | 245 | 3644 | 1400 | 230 | 5.57 | 45.55 | 35.83 | ![]() |
9 | Antibodies![]() | journal | 1.697 Q1 | 42 | 77 | 175 | 4873 | 1108 | 172 | 4.98 | 63.29 | 41.94 | ![]() |
10 | Vaccines![]() | journal | 1.655 Q1 | 85 | 2178 | 2497 | 113547 | 18817 | 2435 | 7.81 | 52.13 | 47.41 | ![]() |
11 | Bioengineering and Translational Medicine![]() | journal | 1.484 Q1 | 28 | 88 | 90 | 6692 | 700 | 79 | 7.78 | 76.05 | 39.20 | ![]() |
12 | Journal of Nanobiotechnology![]() | journal | 1.421 Q1 | 109 | 527 | 729 | 41235 | 7105 | 729 | 9.67 | 78.24 | 40.75 | ![]() |
13 | International Journal of Neuropsychopharmacology![]() | journal | 1.406 Q1 | 125 | 96 | 224 | 5694 | 1192 | 216 | 4.93 | 59.31 | 39.88 | ![]() |
14 | PharmacoEconomics![]() | journal | 1.389 Q1 | 118 | 111 | 344 | 4663 | 1422 | 299 | 3.90 | 42.01 | 48.90 | ![]() |
15 | npj Systems Biology and Applications![]() | journal | 1.388 Q1 | 35 | 49 | 115 | 3441 | 516 | 114 | 4.15 | 70.22 | 26.33 | ![]() |
16 | CNS Neuroscience and Therapeutics![]() | journal | 1.381 Q1 | 91 | 215 | 416 | 11129 | 2529 | 372 | 5.37 | 51.76 | 43.87 | ![]() |
17 | Biomedicine and Pharmacotherapy![]() | journal | 1.366 Q1 | 149 | 1530 | 4036 | 128534 | 32361 | 4020 | 7.78 | 84.01 | 45.39 | ![]() |
18 | Expert Review of Vaccines![]() | journal | 1.346 Q1 | 105 | 178 | 333 | 13191 | 1886 | 316 | 6.10 | 74.11 | 44.05 | ![]() |
19 | Human Genomics![]() | journal | 1.308 Q1 | 68 | 71 | 181 | 4582 | 933 | 173 | 4.26 | 64.54 | 43.70 | ![]() |
20 | PLoS Neglected Tropical Diseases![]() | journal | 1.298 Q1 | 163 | 770 | 2689 | 39961 | 11209 | 2646 | 3.95 | 51.90 | 44.14 | ![]() |
21 | Medicine in Drug Discovery![]() | journal | 1.244 Q1 | 16 | 33 | 37 | 2959 | 260 | 34 | 7.34 | 89.67 | 40.00 | ![]() |
22 | Life Sciences![]() | journal | 1.207 Q1 | 191 | 808 | 3365 | 61614 | 21046 | 3359 | 6.28 | 76.25 | 46.71 | ![]() |
23 | International Journal of Nanomedicine![]() | journal | 1.111 Q1 | 179 | 386 | 1859 | 27026 | 15717 | 1858 | 8.15 | 70.02 | 45.31 | ![]() |
24 | Clinical and Translational Science![]() | journal | 1.084 Q1 | 60 | 269 | 500 | 9314 | 2097 | 461 | 4.25 | 34.62 | 41.67 | ![]() |
25 | Frontiers in Pharmacology![]() | journal | 1.064 Q1 | 154 | 5709 | 7742 | 369866 | 44134 | 7564 | 5.39 | 64.79 | 45.29 | ![]() |
26 | Human Vaccines and Immunotherapeutics![]() | journal | 1.041 Q1 | 93 | 664 | 1584 | 26995 | 6768 | 1418 | 4.29 | 40.66 | 47.71 | ![]() |
27 | International Journal for Parasitology: Drugs and Drug Resistance![]() | journal | 1.038 Q1 | 47 | 34 | 159 | 2431 | 694 | 159 | 4.41 | 71.50 | 32.75 | ![]() |
28 | OpenNano![]() | journal | 1.005 Q1 | 21 | 71 | 7 | 7313 | 62 | 7 | 5.00 | 103.00 | 41.67 | ![]() |
29 | Cancer Biology and Therapy![]() | journal | 0.996 Q1 | 130 | 64 | 356 | 2710 | 1604 | 354 | 3.28 | 42.34 | 38.20 | ![]() |
30 | EPMA Journal![]() | journal | 0.980 Q1 | 52 | 39 | 111 | 3358 | 667 | 110 | 6.68 | 86.10 | 39.93 | ![]() |
31 | EJNMMI Radiopharmacy and Chemistry![]() | journal | 0.972 Q1 | 28 | 33 | 97 | 1487 | 488 | 92 | 4.50 | 45.06 | 29.70 | ![]() |
32 | Nanotheranostics![]() | journal | 0.950 Q1 | 32 | 32 | 84 | 2238 | 433 | 83 | 4.87 | 69.94 | 37.43 | ![]() |
33 | International Journal of Pharmaceutics![]() | journal | 0.906 Q1 | 258 | 969 | 2981 | 57874 | 19166 | 2975 | 6.23 | 59.73 | 44.00 | ![]() |
34 | Drug Design, Development and Therapy![]() | journal | 0.887 Q1 | 94 | 294 | 1226 | 16619 | 6259 | 1219 | 4.83 | 56.53 | 45.48 | ![]() |
35 | Cancer Nanotechnology![]() | journal | 0.882 Q1 | 36 | 42 | 59 | 2014 | 380 | 57 | 4.96 | 47.95 | 43.21 | ![]() |
36 | Biomarker Insights![]() | journal | 0.878 Q2 | 40 | 32 | 51 | 2034 | 182 | 44 | 3.51 | 63.56 | 44.16 | ![]() |
37 | F1000Research![]() | journal | 0.871 Q1 | 105 | 711 | 2008 | 23832 | 6402 | 1974 | 2.96 | 33.52 | 42.41 | ![]() |
38 | Toxins![]() | journal | 0.870 Q1 | 116 | 883 | 2450 | 54545 | 11796 | 2412 | 4.33 | 61.77 | 45.66 | ![]() |
39 | Diabetes, Metabolic Syndrome and Obesity![]() | journal | 0.851 Q2 | 64 | 345 | 1168 | 15791 | 4417 | 1157 | 3.41 | 45.77 | 46.62 | ![]() |
40 | Drug Delivery![]() | journal | 0.846 Q1 | 95 | 267 | 499 | 15439 | 3165 | 498 | 6.07 | 57.82 | 43.76 | ![]() |
41 | Drugs in Context![]() | journal | 0.845 Q2 | 36 | 61 | 183 | 3786 | 735 | 183 | 2.96 | 62.07 | 55.06 | ![]() |
42 | Infection and Drug Resistance![]() | journal | 0.840 Q2 | 65 | 724 | 1399 | 27329 | 6112 | 1383 | 4.13 | 37.75 | 43.59 | ![]() |
43 | Journal of Enzyme Inhibition and Medicinal Chemistry![]() | journal | 0.814 Q1 | 92 | 206 | 538 | 11228 | 3096 | 538 | 5.87 | 54.50 | 44.54 | ![]() |
44 | Marine Drugs![]() | journal | 0.813 Q1 | 159 | 787 | 2083 | 54515 | 12871 | 2059 | 5.67 | 69.27 | 45.52 | ![]() |
45 | Cancer Chemotherapy and Pharmacology![]() | journal | 0.811 Q1 | 122 | 129 | 624 | 4183 | 1952 | 614 | 2.94 | 32.43 | 42.91 | ![]() |
46 | Pharmacological Reports![]() | journal | 0.802 Q2 | 98 | 104 | 473 | 7387 | 1949 | 469 | 4.59 | 71.03 | 48.83 | ![]() |
47 | Journal of Pharmacological Sciences![]() | journal | 0.801 Q2 | 101 | 108 | 346 | 4695 | 1254 | 346 | 3.55 | 43.47 | 30.14 | ![]() |
48 | Therapeutic Advances in Vaccines and Immunotherapy![]() | journal | 0.800 Q2 | 13 | 17 | 41 | 972 | 137 | 37 | 2.87 | 57.18 | 45.24 | ![]() |
49 | Pharmaceuticals![]() | journal | 0.799 Q1 | 87 | 1580 | 2000 | 114308 | 9707 | 1991 | 4.69 | 72.35 | 46.87 | ![]() |
50 | American Journal of Pharmaceutical Education![]() | journal | 0.798 Q1 | 78 | 139 | 619 | 3108 | 1410 | 523 | 2.39 | 22.36 | 68.69 | ![]() |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®